Corbevax likely to be available at vaccination centres from today, know price, features, other details

The recently approved heterologous Covid-19 vaccine, Biological E Limited (BE) Corbevax is expected to be available as a booster dose on the COWIN App in both public and private vaccination centres from today - August 12, 2022. 

Corbevax was approved as India's First Heterologous Covid-19 Booster Shot for 18 Years and above after six months of administration of the primary vaccination doses of Covaxin or Covishield. People who have taken Covaxin or Covishield can be administrated a Corbevax booster shot in "emergency use authorisation". 

READ | "ED, CBI can set up offices at my house if..": Tejashwi Yadav takes jibe at BJP over handling of central agencies

The Union Health Ministry approved Corbevax for emergency use based on a recently made recommendation by the Covid-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI).

"This approval came after the Drug Controller General of India (DCGI) approved the vaccine for emergency use as a heterologous COVID-19 booster dose for individuals aged 18 years on June 4, 2022," an official statement from the BE said.

It further added that the Corbevax had received emergency use authorisation as a primary two-dose vaccination regimen in Adults, Adolescents, and Children aged 5 years and above, in a series of approvals from December '21 to April '22. 

READ | Shocking! Andhra Pradesh woman walks into police station with severed head of daughter-in-law, know what happened

The Hyderabad-based pharmaceutical company (BE) has, so far, delivered 10 crore doses of Corbevax to the Centre. "Pan-India roll-out of the booster shot vaccine in children aged between 12 to 14 years was initiated on March 16, 2022, and till now almost 7 crore doses have been administered and 2.9 crore children completed their two-dose vaccination regimen," it said.

According to the manufacturer company, the vaccine has undergone comprehensive booster trials on Indian subjects and subsequently received approval from the Indian regulatory authority.

BE's Corbevax is the first Indian vaccine to be approved as a heterologous COVID-19 booster dose. It uses a traditional recombinant protein-based technology, which is also used for vaccines such as Hepatitis B.

How is Covid-19 vaccine Corbevax priced?

The price of Corbevax for private Covid-19 vaccination centres is Rs 250, inclusive of the Goods and Sales tax. For the end-user, the price of the vaccine is Rs 400, including taxes and administrative charges. Corbevax is expected to be available as a booster dose on the CoWIN App in public and private vaccination centres from August 12, 2022.